We are live on ! Find out more
WP

Waycross Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 20.92%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
AUM
$188M
AUM Growth
+$8.82M
Cap. Flow
-$7.68M
Cap. Flow %
-4.08%
Top 10 Hldgs %
39.03%
Holding
92
New
Increased
16
Reduced
25
Closed
11

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.11M
2
C icon
Citigroup
C
+$1.12M
3
ADSK icon
Autodesk
ADSK
+$599K
4
INTU icon
Intuit
INTU
+$542K
5
V icon
Visa
V
+$503K

Sector Composition

Rank Sector Weight
1 Technology 22.51%
2 Financials 20.21%
3 Healthcare 18.37%
4 Consumer Discretionary 9.84%
5 Industrials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTAP icon
51
NetApp
NTAP
$32.1B
$1.07M 0.57%
13,100
PZZA icon
52
Papa John's
PZZA
$1.08B
$1.04M 0.55%
10,000
CVS icon
53
CVS Health
CVS
$137B
$1.03M 0.55%
12,400
ADSK icon
54
Autodesk
ADSK
$46.1B
$1.02M 0.54%
3,500
+2,100
+150% +$599K
GILD icon
55
Gilead Sciences
GILD
$167B
$964K 0.51%
14,000
ATVI
56
DELISTED
Activision Blizzard
ATVI
$954K 0.51%
10,000
FLR icon
57
Fluor
FLR
$6.85B
$888K 0.47%
50,168
-2,309
-4% -$47.6K
PXD
58
DELISTED
Pioneer Natural Resource Co.
PXD
$813K 0.43%
5,000
-9,500
-66% -$1.49M
ABT icon
59
Abbott
ABT
$175B
$729K 0.39%
6,289
NKE icon
60
Nike
NKE
$64.9B
$726K 0.39%
4,700
FISV
61
Fiserv Inc
FISV
$27B
$695K 0.37%
6,500
PEP icon
62
PepsiCo
PEP
$187B
$657K 0.35%
4,433
VRTX icon
63
Vertex Pharmaceuticals
VRTX
$123B
$595K 0.32%
2,951
PG icon
64
Procter & Gamble
PG
$349B
$581K 0.31%
4,309
LMT icon
65
Lockheed Martin
LMT
$117B
$549K 0.29%
1,450
SBUX icon
66
Starbucks
SBUX
$120B
$503K 0.27%
4,500
+1,725
+62% +$195K
PFE icon
67
Pfizer
PFE
$143B
$499K 0.27%
12,745
CL icon
68
Colgate-Palmolive
CL
$74.4B
$488K 0.26%
6,000
DXCM icon
69
DexCom
DXCM
$29.6B
$470K 0.25%
4,400
NCLH icon
70
Norwegian Cruise Line
NCLH
$8.93B
$441K 0.23%
15,000
BMRN icon
71
BioMarin Pharmaceuticals
BMRN
$11.5B
$384K 0.2%
4,600
BMY icon
72
Bristol-Myers Squibb
BMY
$124B
$304K 0.16%
4,557
JNJ icon
73
Johnson & Johnson
JNJ
$609B
$280K 0.15%
1,700
SAGE
74
DELISTED
Sage Therapeutics
SAGE
$210K 0.11%
3,700
PM icon
75
Philip Morris
PM
$301B
$160K 0.09%
1,619

Similar funds

Waycross Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Waycross Partners held 92 positions worth $188M, up 4.9% from $179M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Waycross Partners withdrew a net $7.68M in Q2 2021, closing 11 positions and reducing 25 holdings. Its most notable exit was GE Aerospace, an estimated $1.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Waycross Partners added an estimated $3.11M to AbbVie.

  • Waycross Partners added most to AbbVie in Q2 2021, an estimated $3.11M increase.
  • Waycross Partners's biggest Q2 2021 reduction was Pultegroup, cutting an estimated $3.58M.
  • Waycross Partners fully exited GE Aerospace in Q2 2021, selling an estimated $1.26M.
  • Waycross Partners's ten largest holdings make up 39% of its $188M portfolio in Q2 2021.
  • Waycross Partners opened 0 new positions and closed 11 in Q2 2021.
  • Waycross Partners's portfolio value rose 4.9% quarter-over-quarter to $188M.

Based on Waycross Partners's 13F filing for Q2 2021, filed 13 Aug 2021.